Research
We are driving the next generation of discoveries to address critical cancer challenges and accelerate the translation of scientific evidence into patient benefit.
Education
Fostering an outstanding cancer care workforce to help maintain and enhance world-leading patient outcomes through online learning, courses and events.
Equity
Pursuing equity in access to cancer care and outcomes for all Victorians affected by cancer.
About us
Research, academic and clinical institutions working together to accelerate cancer research, knowledge and expertise to benefit all.
News & Events
The VCCC Alliance brings you the latest in cancer research, education and clinical care through engaging, relevant and informative events.

MLL: AI application in early oral cancer detection

In this insightful webinar, Dr Tami Yap and Dr Rishi Ramani explore how machine learning, computer vision, and novel in vivo imaging tools are reshaping the landscape of oral cancer diagnosis. Learn how advances in digital photography, and confocal microscopy now allow us to screen for diseases in real time.

AI application in advancing prediction, early detection and non-invasive imaging techniques in oral cancer.

This talk explores how machine learning, computer vision, and novel in vivo imaging tools are reshaping the landscape of oral cancer diagnosis. Traditional approaches rely on static biopsy samples and subjective clinical interpretation, but advances in digital photography, and confocal microscopy now allow us to screen for diseases in real time. By applying deep learning algorithms to diagnostic imaging, we can detect subtle tissue changes that precede malignancy, opening new possibilities for earlier and more accurate detection.

Beyond the lab, these innovations align with a growing need for equitable access through telehealth. DSLR-based imaging, combined with intelligent diagnostic software, enables remote specialist consultation and risk-based screening across underserved regions. The convergence of continuous data modelling, computer vision, and telehealth platforms holds the promise of transforming oral cancer detection, from a reactive process to a proactive, accessible, and intelligent system of care.

Speakers

Dr Tami Yap
Senior Lecturer, Melbourne Dental School, the University of Melbourne

Dr Tami Yap is the Lead for Impact and Engagement and Co-Lab Head of the Oral Medicine & Oral Cancer Group at the Melbourne Dental School. Her translative research focus is on early detection of oral cancer and oral mucosal disease. She is an Australian registered Oral Medicine Specialist, a fellow of the Royal Australasian College of Dental Surgeons and Pierre Fauchard Academy. Tami has appointments at the Royal Melbourne Hospital, the Royal Dental Hospital of Melbourne, the Alfred Hospital and the Skin and Cancer Foundation of Victoria, Australia.

Dr Rishi Ramani
Research assistant & PhD candidate, Melbourne Dental School, the University of Melbourne

Dr Rishi Ramani is a dentist and data science researcher specialising in oral medicine, biomedical image analysis, and artificial intelligence. A PhD candidate at the University of Melbourne, his work applies deep learning and in vivo confocal microscopy to improve early detection of oral potentially malignant disorders and oral cancer. He is a Research Assistant at the Melbourne Dental School, Associate Editor for the Journal of Oral Pathology and Medicine and co-leads a project within the ITU–WHO–WIPO Global Initiative on AI for Health, shaping international guidelines on dental AI.

 

Chair

Dr Sophie Beaumont
Manager Dental Oncology,
Peter MacCallum Cancer Centre

Sophie is a dental practitioner and the current head of the dental oncology department at Peter Mac. She has worked extensively in the public healthcare sector for most of her career, and is passionate about delivering  equitable, high quality dental and oral healthcare to all our Peter Mac patients.

Monday 29 September
1.00–2.00pm

Get the latest in cancer news, events and more, direct to your inbox

Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.